Researchers found that subcutaneous application of umbilical cord-derived MSCs primed by interferon-γ and tumor necrosis factor-α exhibited remarkable therapeutic efficacy on imiquimod-induced psoriasis-like inflammation in mice.
[Cell Death & Disease]